Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder
Launched by UNIVERSITY OF COLORADO, DENVER · Jul 24, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the treatment of opioid use disorder (OUD) through a system called clinical decision support (CDS). The goal is to help doctors identify patients who may be at risk for OUD and to guide them in prescribing the right medications for treatment. The study will involve primary care providers who will be divided into two groups: one group will receive reminders to use the CDS pathway when treating patients with OUD, while the other group will have access to the pathway but won’t receive reminders. Researchers will look at how often doctors prescribe buprenorphine, a medication that helps treat OUD, and the health outcomes of patients over about 18 months.
To participate in this trial, individuals must have had a visit with a primary care doctor and be currently using opioids (not including buprenorphine) or meet specific criteria related to pain management and opioid use. Some examples of eligibility include having a recent opioid prescription, being on a local Pain Registry, or having a diagnosis of opioid use disorder. However, those with certain conditions, such as active cancer or receiving hospice care, will not be included. If eligible, participants can expect their medical records to be reviewed as part of the study to understand how treatment impacts their health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary care encounter AND
- • Current opioid prescription (not buprenorphine) and Active opioid medications over the last 90 days OR
- • Documented as on local Pain Registry "Does the patient fit the criteria to be included on the Pain Registry?" OR
- • Has active problem list diagnosis of long-term (current) use of opiate analgesic OR
- • Is taking \>=90 morphine milligram equivalents (MME) per day OR
- • Prior positive toxicology screen for illicit drugs OR
- • Diagnosis of opioid use disorder
- Exclusion Criteria:
- • Active cancer diagnosis in the last 1 year
- • Hospice care/palliative care order
- • Sickle cell disease diagnosis
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jason Hoppe, DO
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported